BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18662957)

  • 1. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
    Gutierrez A; Rodriguez J
    Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
    Mercadal S; Briones J; Xicoy B; Pedro C; Escoda L; Estany C; Camós M; Colomo L; Espinosa I; Martínez S; Ribera JM; Martino R; Gutiérrez-García G; Montserrat E; López-Guillermo A;
    Ann Oncol; 2008 May; 19(5):958-63. PubMed ID: 18303032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
    Schmitz N; Truemper L; Bouabdallah K; Ziepert M; Leclerc M; Cartron G; Jaccard A; Reimer P; Wagner E; Wilhelm M; Sanhes L; Lamy T; de Leval L; Rosenwald A; Roussel M; Kroschinsky F; Lindemann W; Dreger P; Viardot A; Milpied N; Gisselbrecht C; Wulf G; Gyan E; Gaulard P; Bay JO; Glass B; Poeschel V; Damaj G; Sibon D; Delmer A; Bilger K; Banos A; Haenel M; Dreyling M; Metzner B; Keller U; Braulke F; Friedrichs B; Nickelsen M; Altmann B; Tournilhac O
    Blood; 2021 May; 137(19):2646-2656. PubMed ID: 33512419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
    Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].
    Pérez-Barrio S; Izu R; García-Ruiz JC; Acebo E; Martínez de Lagrán Z; Díaz-Pérez JL
    Actas Dermosifiliogr; 2008 Sep; 99(7):560-4. PubMed ID: 18682170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
    Kamata M; Sugaya M; Miyagaki T; Sonoda K; Ichimura Y; Mitsui H; Sato S; Kamikubo Y; Kurokawa M
    Int J Dermatol; 2014 Jan; 53(1):e24-6. PubMed ID: 23452101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant lymphoma and adult T-cell leukemia-lymphoma].
    Kato K
    Rinsho Ketsueki; 2014 Feb; 55(2):191-200. PubMed ID: 24598187
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.
    Lefrère F; Delmer A; Levy V; Delarue R; Varet B; Hermine O
    Haematologica; 2004 Oct; 89(10):1275-6. PubMed ID: 15477221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
    Yamaguchi M; Kotani T; Nakamura Y; Ueda M
    Int J Hematol; 2006 Jun; 83(5):450-3. PubMed ID: 16787878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
    Ordemann R; Stöhlmacher J; Beuthien-Baumann B; Platzek I; van den Hoff J; Kroschinsky F; Middeke JM; Platzbecker U; Zietz C; Bornhäuser M; Ehninger G
    Ann Hematol; 2013 Jan; 92(1):125-7. PubMed ID: 22820970
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
    Zheng W; Zhu J; Xie Y
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
    Tsujimura H; Takagi T; Tamaru J; Sakai C
    Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
    Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
    Kouzaki H; Kitanishi T; Kitano H; Suzuki M
    Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful allogeneic stem cell transplantation for Lennert lymphoma.
    Uni M; Yoshimi A; Nakamura F; Takazawa Y; Fukayama M; Kurokawa M
    Ann Hematol; 2013 Jun; 92(6):859-60. PubMed ID: 23224245
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.
    Novella E; Madeo D; Albiero E; Roberti S; Castaman G; Elice F; Rodeghiero F
    Leuk Lymphoma; 2004 Jul; 45(7):1497-9. PubMed ID: 15359659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.